Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients.
Bibert S, Guex N, Lourenco J, Brahier T, Papadimitriou-Olivgeris M, Damonti L, Manuel O, Liechti R, Götz L, Tschopp J, Quinodoz M, Vollenweider P, Pagani JL, Oddo M, Hügli O, Lamoth F, Erard V, Voide C, Delorenzi M, Rufer N, Candotti F, Rivolta C, Boillat-Blanco N, Bochud PY; RegCOVID Study Group.
Bibert S, et al. Among authors: damonti l.
Front Immunol. 2021 May 31;12:666163. doi: 10.3389/fimmu.2021.666163. eCollection 2021.
Front Immunol. 2021.
PMID: 34135895
Free PMC article.